Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Dow"

527 News Found

Roche retains its sustainability ranking in the Dow Jones Sustainability Indices
Sustainability | November 15, 2021

Roche retains its sustainability ranking in the Dow Jones Sustainability Indices

The company performed particularly well in operational eco-efficiency, environmental and social reporting


INNOVIO QoQ revenues down for the period ended June 30, 2021
Biotech | August 10, 2021

INNOVIO QoQ revenues down for the period ended June 30, 2021

Company working on COVID vaccine INO 4800


Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations
People | August 01, 2025

Bio-Rad names Rajat Mehta as EVP - Global Commercial Operations

Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics


Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
People | July 31, 2025

Maziar Mike Doustdar appointed President and CEO of Novo Nordisk

Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit


Astec LifeSciences Q1 FY26 revenue up 30.3%
News | July 29, 2025

Astec LifeSciences Q1 FY26 revenue up 30.3%

The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year


Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries
Opinion | July 28, 2025

Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries

The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production


Granules India CEO K V Sitaram Rao resigns
People | July 27, 2025

Granules India CEO K V Sitaram Rao resigns

Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service


Dr. Reddy’s infuses Rs. 565 crore in its Russian subsidiary
News | July 27, 2025

Dr. Reddy’s infuses Rs. 565 crore in its Russian subsidiary

The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%


Duke Street Bio receives FDA fast track designation for PARP1-selective inhibitor with CNS activity
Biotech | July 08, 2025

Duke Street Bio receives FDA fast track designation for PARP1-selective inhibitor with CNS activity

Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need


GACL flags of first dispatch of Benzyl Alcohol and Benzaldehyde
News | July 06, 2025

GACL flags of first dispatch of Benzyl Alcohol and Benzaldehyde

The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde